Predilife (ALPRE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.219x

Based on the latest financial reports, Predilife (ALPRE) has a cash flow conversion efficiency ratio of 0.219x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.28 Million ≈ $-1.49 Million USD) by net assets (€-5.82 Million ≈ $-6.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALPRE company net worth for the company's overall valuation and market capitalisation.

Predilife - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Predilife's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Predilife Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Predilife ranked by their cash flow conversion efficiency. See Predilife (ALPRE) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Sulliden Minerals SA TO:SMC	0.090x
Sultan Resources Ltd AU:SLZ	-0.130x
Neola Medical AB ST:NEOLA	-0.025x
ASIA Capital Group Public Company Limited BK:ACAP	0.032x
Mears Group plc LSE:MER	0.354x
Xpon Technologies Group Ltd AU:XPN	-1.594x
Lion Energy Ltd AU:LIO	-0.111x
Rare Earth Magnesium Technology Group Holdings Limited STU:GPS	0.016x

Annual Cash Flow Conversion Efficiency for Predilife (2016–2024)

The table below shows the annual cash flow conversion efficiency of Predilife from 2016 to 2024. View Predilife (ALPRE) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-4.27 Million ≈ $-4.99 Million	€-3.72 Million ≈ $-4.35 Million	0.872x	+110.59%
2023-12-31	€513.52K ≈ $600.36K	€-4.23 Million ≈ $-4.94 Million	-8.236x	-1502.63%
2022-12-31	€-5.22 Million ≈ $-6.10 Million	€-3.07 Million ≈ $-3.58 Million	0.587x	-75.98%
2021-12-31	€-1.57 Million ≈ $-1.83 Million	€-3.83 Million ≈ $-4.47 Million	2.445x	+183.67%
2020-12-31	€721.69K ≈ $843.73K	€-2.11 Million ≈ $-2.47 Million	-2.922x	-193.26%
2019-12-31	€-764.29K ≈ $-893.53K	€-2.39 Million ≈ $-2.80 Million	3.133x	-97.90%
2018-12-31	€-12.10K ≈ $-14.15K	€-1.81 Million ≈ $-2.11 Million	149.479x	+12560.50%
2017-12-31	€-1.29 Million ≈ $-1.51 Million	€-1.53 Million ≈ $-1.78 Million	1.181x	+131.59%
2016-12-31	€362.63K ≈ $423.95K	€-1.36 Million ≈ $-1.58 Million	-3.737x	--

About Predilife

PA:ALPRE France Diagnostics & Research

Market Cap

$4.17 Million

€3.57 Million EUR

Market Cap Rank

#29021 Global

#520 in France

Share Price

€0.91

Change (1 day)

+0.00%

52-Week Range

€0.91 - €3.54

All Time High

€15.90